KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

OSPAMOX 500 MG FC TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

500 MG

 

GENERIC NAME:

AMOXICILLIN

 

MANUFACTURER:

BIOCHEMIE GESELLSCHAFT

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

B

 

INDICATIONS:

Gonorrhea

Infection, ear, middle

Infection, genital tract

Infection, lower respiratory tract

Infection, sinus

Infection, skin and skin structure

Infection, upper respiratory tract

Infection, urinary tract

Pharyngitis

Pneumonia

Tonsillitis

Ulcer, H. pylori associated

 

SIDE EFFECTS:

abdominal pain

acute generalized exanthematous pustulosis (AGEP)

agranulocytosis

anaphylactic shock

anaphylactoid reactions

anemia

anorexia

bullous rash

candidiasis

cholestasis

colitis

crystalluria

dental fluorosis

diarrhea

dizziness

dysphagia

elevated hepatic enzymes

eosinophilia

erythema multiforme

esophagitis

exfoliative dermatitis

gastritis

headache

hemolysis

hemolytic anemia

hepatitis

insomnia

interstitial nephritis

jaundice

leukopenia

maculopapular rash

nausea/vomiting

nephrotic syndrome

neutropenia

odynophagia

platelet dysfunction

prolonged bleeding time

pseudomembranous colitis

purpura

rash (unspecified)

seizures

serum sickness

Stevens-Johnson syndrome

superinfection

thrombocytopenia

tooth discoloration

toxic epidermal necrolysis

urticaria

vasculitis

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

asthma

breast-feeding

carbapenem hypersensitivity

cephalosporin hypersensitivity

colitis

diabetes mellitus

dialysis

diarrhea

eczema

GI disease

infants

infection

leukemia

mononucleosis

neonates

phenylketonuria

pregnancy

renal failure

renal impairment

syphilis

 

ADULT DOSE:

Antibacterial- Ear, nose, and throat infections: Mild or moderate-Oral, 500 mg every twelve hours or 250 mg every eight hours. Severe-Oral, 875 mg every twelve hours or 500 mg every eight hours. Lower respiratory tract infections: Mild, moderate, or severe-Oral, 875 mg every twelve hours or 500 mg every eight hours. Skin or skin structure infections: Mild or moderate-Oral, 500 mg every twelve hours or 250 mg every eight hours. Severe-Oral, 875 mg every twelve hours or 500 mg every eight hours. Genitourinary tract infections: Mild or moderate-Oral, 500 mg every twelve hours or 250 mg every eight hours. Severe-Oral, 875 mg every twelve hours or 500 mg every eight hours. Gonorrhea, acute uncomplicated (anogenital and urethral infections): Oral, 3 grams as a single dose. Endocarditis, bacterial (prophylaxis): Oral, 3 grams one hour before the procedure, then 1.5 grams six hours after the initial dose. Duodenal ulcer, Helicobacter pylori -associated : Triple antibiotic therapy: Oral, 1000 mg amoxicillin with 500 mg clarithromycin and 30 mg lansoprazole two times a day at twelve-hour intervals for fourteen days. Dual antibiotic therapy: Oral, 1000 mg amoxicillin with 30 mg lansoprazole three times a day at eight-hour intervals for fourteen days. [Chlamydia, treatment in pregnant women] : Oral, 500 mg every eight hours for seven to ten days. [Gastritis, Helicobacter pylori] or [Ulcer, peptic, Helicobacter pylori] : Oral, 500 mg four times a day; or 750 mg three times a day. [Lyme disease] : Oral, 250 to 500 mg three or four times a day for three to four weeks. Duration of therapy is based on clinical response. Treatment failures have occurred and retreatment may be necessary. Patients with severe renal function impairment require an adjustment in dosage as follows : Patients with a glomerular filtration rate of 10-30 mL per minute-Oral, 500 mg or 250 mg every twelve hours, depending on the severity of the infection. Patients with a glomerular filtration rate of < 10 mL per minute-Oral, 500 mg or 250 mg every twenty-four hours, depending on the severity of the infection. Patients on hemodialysis-Oral, 500 mg or 250 mg every twenty-four hours, depending on the severity of the infection. An additional dose should be administered both during and at the end of the dialysis session. Note: Patients with severe renal function impairment (glomerular filtration rate of < 30 mL per minute) should not receive the 875-mg tablet.

 

MAXIMUM ADULT DOSE:

4.5 grams a day.

 

PEDIATRIC DOSE:

Antibacterial- Gonorrhea, endocervical and urethral, uncomplicated: Oral, 50 mg per kg of body weight and 25 mg of probenecid per kg of body weight simultaneously as a single dose in prepubertal children. However, probenecid is not recommended in children under 2 years of age. Duodenal ulcer, Helicobactor pylori -associated : Safety and efficacy have not been established for pediatric or adolescent patients. [Lyme disease] : Oral, 6.7 to 13.3 mg per kg of body weight every eight hours for ten to thirty days. Duration of therapy is based on clinical response. Treatment failures have occurred and retreatment may be necessary. For all other indications: Infants and children up to 40 kg of body weight, see Amoxicillin for Oral Suspension USP . Children 40 kg of body weight and over-See Usual adult dose. 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT